Long-Term Follow-up of Treatment-Emergent Resistance-Associated Variants in Ns3, Ns5a and Ns5b with Paritaprevir/R-, Ombitasvir- and Dasabuvir-Based Regimens - Krishnan, P; Tripathi, R; Schnell, G (Journal of hepatology, 2015)
et al.